QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, October 15, 2003, 23(28):9276-9288

This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (76) Citing Articles via Google Scholar Google Scholar Articles by Jones, L. L. Articles by Tuszynski, M. H. Search for Related Content PubMed PubMed Citation Articles by Jones, L. L. Articles by Tuszynski, M. H.

 Previous Article  |  Next Article 

Behavioral/Systems/Cognitive
Axonal Regeneration through Regions of Chondroitin Sulfate Proteoglycan Deposition after Spinal Cord Injury: A Balance of Permissiveness and Inhibition

Leonard L. Jones,^1,2 Dana Sajed,¹ and Mark H. Tuszynski^1,2

¹Department of Neurosciences, University of California-San Diego, La Jolla, California 92093, and ²Veterans Affairs Medical Center, San Diego, California 92161

Increased expression of certain extracellular matrix (ECM) molecules after CNS injury is believed to restrict axonal regeneration. The chondroitin sulfate proteoglycans (CSPGs) are one such class of ECM molecules that inhibit neurite outgrowth in vitro and are upregulated after CNS injury. We examined growth responses of several classes of axons to this inhibitory environment in the presence of a cellular fibroblast bridge in a spinal cord lesion site and after a growth factor stimulus at the lesion site (fibroblasts genetically modified to secrete NGF). Immunohistochemical analysis showed dense labeling of the CSPGs NG2, brevican, neurocan, versican, and phosphacan at the host-lesion interface after spinal cord injury (SCI). Furthermore, robust expression of NG2, and to a lesser extent versican, was also observed throughout grafts of control and NGF-secreting fibroblasts. Despite this inhibitory milieu, several axonal classes penetrated control fibroblast grafts, including dorsal column sensory, rubrospinal, and nociceptive axons. Axon growth was amplified more in the presence of NGF-secreting grafts. Confocal microscopy demonstrated that axon growth was, paradoxically, preferentially associated with NG2-rich substrates in both graft types. NG2 expression also increased after sciatic nerve injury, wherein axons successfully regenerate. Cellular sources of NG2 in SCI and peripheral nerve lesion sites included Schwann cells and endothelial cells. Notably, these same cellular sources in lesion sites produced the cell adhesion molecules L1 and laminin, and these molecules all colocalized. Thus, axons grow along substrates coexpressing both inhibitory and permissive molecules, suggesting that regeneration is successful when local permissive signals balance and exceed inhibitory signals.

Key words: regeneration; chondroitin sulfate proteoglycans; extracellular matrix; spinal cord injury; inhibition; cell adhesion

---

Received July 18, 2003; revised August 19, 2003; accepted August 19, 2003.

This article has been cited by other articles:

				H. Beck, M. Semisch, C. Culmsee, N. Plesnila, and A. K. Hatzopoulos Egr-1 Regulates Expression of the Glial Scar Component Phosphacan in Astrocytes after Experimental Stroke Am. J. Pathol., July 1, 2008; 173(1): 77 - 92. [Abstract] [Full Text] [PDF]

				S. Singhal, J. M. Lawrence, B. Bhatia, J. S. Ellis, A. S. Kwan, A. MacNeil, P. J. Luthert, J. W. Fawcett, M.-T. Perez, P. T. Khaw, et al. Chondroitin Sulfate Proteoglycans and Microglia Prevent Migration and Integration of Grafted Muller Stem Cells into Degenerating Retina Stem Cells, April 1, 2008; 26(4): 1074 - 1082. [Abstract] [Full Text] [PDF]

				K. Low, M. Culbertson, F. Bradke, M. Tessier-Lavigne, and M. H. Tuszynski Netrin-1 Is a Novel Myelin-Associated Inhibitor to Axon Growth J. Neurosci., January 30, 2008; 28(5): 1099 - 1108. [Abstract] [Full Text] [PDF]

				K. S. Ziemba, N. Chaudhry, A. G. Rabchevsky, Y. Jin, and G. M. Smith Targeting Axon Growth from Neuronal Transplants along Preformed Guidance Pathways in the Adult CNS J. Neurosci., January 9, 2008; 28(2): 340 - 348. [Abstract] [Full Text] [PDF]

				A. Nishiyama Polydendrocytes: NG2 Cells with Many Roles in Development and Repair of the CNS Neuroscientist, February 1, 2007; 13(1): 62 - 76. [Abstract] [PDF]

				P. Lu, H. Yang, M. Culbertson, L. Graham, A. J. Roskams, and M. H. Tuszynski Olfactory Ensheathing Cells Do Not Exhibit Unique Migratory or Axonal Growth-Promoting Properties after Spinal Cord Injury J. Neurosci., October 25, 2006; 26(43): 11120 - 11130. [Abstract] [Full Text] [PDF]

				J. D. Houle, V. J. Tom, D. Mayes, G. Wagoner, N. Phillips, and J. Silver Combining an autologous peripheral nervous system "bridge" and matrix modification by chondroitinase allows robust, functional regeneration beyond a hemisection lesion of the adult rat spinal cord. J. Neurosci., July 12, 2006; 26(28): 7405 - 7415. [Abstract] [Full Text] [PDF]

				A. M. Tan, M. Colletti, A. T. Rorai, J. H. P. Skene, and J. M. Levine Antibodies against the NG2 proteoglycan promote the regeneration of sensory axons within the dorsal columns of the spinal cord. J. Neurosci., May 3, 2006; 26(18): 4729 - 4739. [Abstract] [Full Text] [PDF]

				Z. Yang, R. Suzuki, S. B. Daniels, C. B. Brunquell, C. J. Sala, and A. Nishiyama NG2 glial cells provide a favorable substrate for growing axons. J. Neurosci., April 5, 2006; 26(14): 3829 - 3839. [Abstract] [Full Text] [PDF]

				H. Yang, P. Lu, H. M. McKay, T. Bernot, H. Keirstead, O. Steward, F. H. Gage, V. R. Edgerton, and M. H. Tuszynski Endogenous neurogenesis replaces oligodendrocytes and astrocytes after primate spinal cord injury. J. Neurosci., February 22, 2006; 26(8): 2157 - 2166. [Abstract] [Full Text] [PDF]

				C. Girard, A.-P. Bemelmans, N. Dufour, J. Mallet, C. Bachelin, B. Nait-Oumesmar, A. Baron-Van Evercooren, and F. Lachapelle Grafts of Brain-Derived Neurotrophic Factor and Neurotrophin 3-Transduced Primate Schwann Cells Lead to Functional Recovery of the Demyelinated Mouse Spinal Cord J. Neurosci., August 31, 2005; 25(35): 7924 - 7933. [Abstract] [Full Text] [PDF]

				X. Bao, T. Mikami, S. Yamada, A. Faissner, T. Muramatsu, and K. Sugahara Heparin-binding Growth Factor, Pleiotrophin, Mediates Neuritogenic Activity of Embryonic Pig Brain-derived Chondroitin Sulfate/Dermatan Sulfate Hybrid Chains J. Biol. Chem., March 11, 2005; 280(10): 9180 - 9191. [Abstract] [Full Text] [PDF]

				C. Gotting, S. Muller, M. Schottler, S. Schon, C. Prante, T. Brinkmann, J. Kuhn, and K. Kleesiek Analysis of the DXD Motifs in Human Xylosyltransferase I Required for Enzyme Activity J. Biol. Chem., October 8, 2004; 279(41): 42566 - 42573. [Abstract] [Full Text] [PDF]

				P. Lu, H. Yang, L. L. Jones, M. T. Filbin, and M. H. Tuszynski Combinatorial Therapy with Neurotrophins and cAMP Promotes Axonal Regeneration beyond Sites of Spinal Cord Injury J. Neurosci., July 14, 2004; 24(28): 6402 - 6409. [Abstract] [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help